DYNE THERAPEUTICSCS INC Share · US26818M1080 · DYN (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of DYNE THERAPEUTICSCS INC

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

01.05.2026 19:39

Current Prices from DYNE THERAPEUTICSCS INC

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
IEX	DYN	USD	01.05.2026 19:39	17,45 USD	-0,11 USD -0,60 %
NASDAQ	DYN	USD	01.05.2026 19:23	17,52 USD	-0,03 USD -0,16 %

Share Float & Liquidity

Free Float 77,34 %

Shares Float 127,79 M

Shares Outstanding 165,22 M

Company Profile for DYNE THERAPEUTICSCS INC Share

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..